Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.24.1.1.u2
STOCKHOLDERS' EQUITY (Details)
 1 Months Ended 3 Months Ended
Sep. 08, 2023
USD ($)
D
$ / shares
shares
Oct. 25, 2022
USD ($)
$ / shares
shares
Oct. 20, 2022
USD ($)
Jan. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
shares
Dec. 31, 2023
$ / shares
shares
STOCKHOLDERS' EQUITY              
Warrants issued to purchase shares         12,529,916    
Proceeds from exercise of warrants, net of issuance costs (Note 2) | $         $ 43,849,467 $ 3  
Common stock, shares authorized         170,000,000   170,000,000
Common stock par value | $ / shares         $ 0.00001   $ 0.00001
Exercise of warrants into common shares | $         $ 1,072,467    
September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Gross proceeds | $ $ 24,500,000            
Net proceeds | $ $ 22,200,000            
Common Stock              
STOCKHOLDERS' EQUITY              
Exercise of warrants into common shares (in shares)         547,177    
Exercise of warrants into common shares | $         $ 5    
Common Stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Conversion of pre-funded warrants into common shares (in shares)         903,956    
Preferred Stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Number of shares converted 905.24            
Common Stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Convertible preferred shares issued 9,947,684            
Series D preferred stock              
STOCKHOLDERS' EQUITY              
Preferred stock, share outstanding         111.11   111.11
Series E Warrants | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Share price | $ / shares $ 20,000            
Series E-1 preferred stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Shares issued 1,225            
Conversion price per share | $ / shares $ 1.82            
Convertible preferred shares issued 13,461,538            
Gross proceeds from stockholders' equity | $ $ 17,920,000            
Series E-2 Preferred Stock              
STOCKHOLDERS' EQUITY              
Preferred stock, share outstanding         237.50   319.76
Series E-2 Preferred Stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Conversion of pre-funded warrants into common shares (in shares)         82.26    
Common stock par value | $ / shares $ 1.82            
Preferred stock, share outstanding         237.50   319.76
Series E-2 Preferred Stock | Common Stock              
STOCKHOLDERS' EQUITY              
Conversion of pre-funded warrants into common shares (in shares)         903,956    
Series E-3 preferred stock              
STOCKHOLDERS' EQUITY              
Preferred stock, share outstanding         630.00   0
Series E-3 preferred stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Conversion price per share | $ / shares $ 3.185     $ 3.185      
Convertible preferred shares issued 13,846,154            
Conversion of pre-funded warrants into common shares (in shares)         9,890,099    
Preferred stock, share outstanding         630.00    
Number of shares converted         1,575.00    
Series E-3 preferred stock | Common Stock              
STOCKHOLDERS' EQUITY              
Conversion of pre-funded warrants into common shares (in shares)         9,890,099    
Series E-4 preferred stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Conversion price per share | $ / shares $ 4.7775            
Convertible preferred shares issued 7,179,487            
Tranche A and B Warrants | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Gross proceeds from stockholders' equity | $ $ 4,700,000            
October 2022 Public Offering and Private Placement              
STOCKHOLDERS' EQUITY              
Warrants issued to purchase shares   3,275,153          
Gross proceeds | $   $ 10,700,000          
Proceeds from exercise of warrants, net of issuance costs (Note 2) | $         $ 1,100,000    
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.085          
Class of warrant or rights from which warrants or rights exercisable. | $ / shares   $ 0.00001          
Estimated offering expenses | $   $ 9,600,000          
Gross proceeds from stockholders' equity | $     $ 10,700,000        
October 2022 Public Offering and Private Placement | Common Stock              
STOCKHOLDERS' EQUITY              
Warrants issued to purchase shares   1,875,945          
Exercise price of warrants (in dollars per share) | $ / shares   $ 1.96          
Common Stock | October 2022 Public Offering and Private Placement              
STOCKHOLDERS' EQUITY              
Conversion of pre-funded warrants into common shares (in shares)         1,079,132    
Gross proceeds from stockholders' equity | $     4,000,000.0        
Common warrants | October 2022 Public Offering and Private Placement              
STOCKHOLDERS' EQUITY              
Gross proceeds from stockholders' equity | $     4,400,000        
Prefunded Warrant | October 2022 Public Offering and Private Placement              
STOCKHOLDERS' EQUITY              
Warrants issued to purchase shares   1,875,945          
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.08499          
pre-funded warrants         1,079,132 0  
Gross proceeds from stockholders' equity | $     $ 2,300,000        
Warrants | October 2022 Public Offering and Private Placement              
STOCKHOLDERS' EQUITY              
Exercise of warrants into common shares (in shares)         547,177 0  
Tranche A Warrants              
STOCKHOLDERS' EQUITY              
Exercise of warrants into common shares | $         $ 42,777,000    
Tranche A Warrants | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Warrants term       10 days      
Tranche A Warrants | Series E-3 preferred stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Proceeds from exercise of warrants, net of issuance costs (Note 2) | $       $ 44,100,000      
Exercise of warrants into common shares (in shares)       2,205.00      
Exercise of warrants into common shares | $       $ 42,800,000      
2023 Tranche A Preferred Warrants | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Proceeds from exercise of warrants, net of issuance costs (Note 2) | $ $ 44,100,000            
2023 Tranche A Preferred Warrants | Series E-3 preferred stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Warrants issued to purchase shares 2,205            
Number of days | D 10            
2023 Tranche B Preferred Warrants | Series E-4 preferred stock | September 2023 Private Placement              
STOCKHOLDERS' EQUITY              
Warrants issued to purchase shares 1,715            
Proceeds from exercise of warrants, net of issuance costs (Note 2) | $ $ 34,300,000            
Number of days | D 10